SARAH LANE: Open Payments
NPI 1306410543 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 15 payments from 8 companies in 2025. Trend: 2023 $942 · 2024 $355 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| GENZYME CORPORATION | 1 | $120 |
| Insmed, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $22 |
| United Therapeutics Corporation | 1 | $18 |
| HARMONY BIOSCIENCES LLC | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Arikayce, XYWAV, AIRSUPRA, WAKIX, YUPELRI.
Industry payments across IA — which companies pay providers there.
